finanzen.net

BioInvent International A Aktie WKN: 677134 / ISIN: SE0000789711

0,0930EUR
+0,0007EUR
+0,76%
14.06.2019
1,39SEK
-0,05SEK
-3,47%
14.06.2019
KAUFEN
VERKAUFEN
mehr Daten anzeigen

BioInvent International A News

12.06.19
BioInvent Publishes First Clinical Data From BI-1206 Phase l/lla Trials (PR Newswire)
03.06.19
BioInvent Submits IND for Phase I/IIa Trial of Anti-Fc?RIIB Antibody (PR Newswire)
03.06.19
BioInvent Submits IND for Phase I/IIa Trial of Anti-Fc?RIIB Antibody (PR Newswire)
24.05.19
BioInvent International A: Bilanz zum abgelaufenen Quartal (finanzen.net)
22.05.19
BioInvent Interim Report January 1 - March 31, 2019 (PR Newswire)
22.05.19
BioInvent Interim Report January 1 - March 31, 2019 (PR Newswire)
26.04.19
BioInvent Receives €0.75 Million Milestone Under Mitsubishi Tanabe Pharma Partnership (PR Newswire)
26.04.19
BioInvent Receives €0.75 Million Milestone Under Mitsubishi Tanabe Pharma Partnership (PR Newswire)
26.03.19
BioInvent and Transgene Extend Their Collaboration to Develop Multifunctional Oncolytic Viruses for the Treatment of Solid Tumors (PR Newswire)
26.03.19
BioInvent and Transgene Extend Their Collaboration to Develop Multifunctional Oncolytic Viruses for the Treatment of Solid Tumors (PR Newswire)
21.03.19
BioInvent Unveils Broad Anti-TNFR2 Program to Treat Solid Tumors (PR Newswire)
21.03.19
BioInvent Unveils Broad Anti-TNFR2 Program to Treat Solid Tumors (PR Newswire)
19.03.19
Notice to Annual General Meeting in BioInvent International AB (PR Newswire)
19.03.19
Notice to Annual General Meeting in BioInvent International AB (PR Newswire)
12.03.19
BioInvent Announces Publication of Review Article in Frontiers in Immunology on Resistance to Antibody Drugs (PR Newswire)
12.03.19
BioInvent Announces Publication of Review Article in Frontiers in Immunology on Resistance to Antibody Drugs (PR Newswire)
25.02.19
Notice of Extraordinary General Meeting in BioInvent International AB (PR Newswire)
25.02.19
Notice of Extraordinary General Meeting in BioInvent International AB (PR Newswire)
25.02.19
BioInvent Financial Statement January 1 - December 31, 2018 (PR Newswire)
25.02.19
BioInvent Financial Statement January 1 - December 31, 2018 (PR Newswire)
05.02.19
BioInvent CSO to Present F.I.R.S.T.™ Discovery Platform at SLAS2019 (PR Newswire)
05.02.19
BioInvent CSO to Present F.I.R.S.T.™ Discovery Platform at SLAS2019 (PR Newswire)
30.01.19
BioInvent Receives FDA Orphan Designation for BI-1206 for Mantle Cell Lymphoma (PR Newswire)
30.01.19
BioInvent Receives FDA Orphan Designation for BI-1206 for Mantle Cell Lymphoma (PR Newswire)
20.11.18
BioInvent Signs Manufacturing Agreement With U.S. Cell Therapy Company (PR Newswire)
20.11.18
BioInvent Signs Manufacturing Agreement With U.S. Cell Therapy Company (PR Newswire)
13.11.18
BioInvent Announces Publication of Data in Leading Cancer Journal Immunity (PR Newswire)
13.11.18
BioInvent Announces Publication of Data in Leading Cancer Journal Immunity (PR Newswire)
07.11.18
Transgene and BioInvent Present Positive Data at the SITC, Supporting the Co-development of a Next-generation Oncolytic Virus Encoding for an Anti-CTLA-4 Antibody (PR Newswire)
07.11.18
Transgene and BioInvent Present Positive Data at the SITC, Supporting the Co-development of a Next-generation Oncolytic Virus Encoding for an Anti-CTLA-4 Antibody (PR Newswire)
17.10.18
BioInvent Embarks on Intensive Investor Meeting Program in the U.S., Europe, and Israel, and Posts Updated Presentation on Corporate Website (PR Newswire)
17.10.18
BioInvent Embarks on Intensive Investor Meeting Program in the U.S., Europe, and Israel, and Posts Updated Presentation on Corporate Website (PR Newswire)
16.10.18
BioInvent to Expand Pipeline With New Development Programs in Solid Cancer (PR Newswire)
16.10.18
BioInvent to Expand Pipeline With New Development Programs in Solid Cancer (PR Newswire)
09.12.16
Bioinvent Terminates Current BI-505 Phase II Study (Businesswire)
08.11.16
BioInvent Reports Clinical Hold on BI-505 Phase II Study (Businesswire)
25.10.16
BioInvent Interim Report 1 January – 30 September 2016 (Businesswire)
19.09.16
BioInvent Expands Patent Approvals for Its Lead Clinical Immuno-Oncology Programme in Multiple Myeloma, BI-505 (Businesswire)
29.08.16
BioInvent Extends Manufacturing Services Contract with Major Global Pharmaceutical Client; Expects to Generate Approximately SEK 8 Million in Revenue (Businesswire)
26.07.16
BioInvent Interim Report 1 January – 30 June 2016 (Businesswire)
Seite: 123

BioInvent International A News

BioInvent International A News: auf dieser Seite finden Sie alle BioInvent International A News und Nachrichten zur BioInvent International A Aktie. Dies beinhaltet die Agentur-Feeds auf finanzen.net, aber auch BioInvent International A News auf einer Vielzahl externer Seiten. Externe Links sind am entsprechenden Link-Symbol zu erkennen. Um BioInvent International A News auf externen Seiten zu lesen, folgen Sie einfach dem entsprechenden Link.

Online Brokerage über finanzen.net

finanzen.net Brokerage
Handeln Sie für nur 5 Euro Orderprovision* pro Trade aus der Informationswelt von finanzen.net!

ETF-Sparplan

Oskar ist der einfache und intelligente ETF-Sparplan. Er übernimmt die ETF-Auswahl, ist steuersmart, transparent und kostengünstig.
Zur klassischen Ansicht wechseln
Kontakt - Impressum - Werben - Pressemehr anzeigen
Top News
Beliebte Suchen
DAX 30
Öl
Euro US-Dollar
Bitcoin
Goldpreis
Meistgesucht
Deutsche Bank AG514000
Microsoft Corp.870747
Scout24 AGA12DM8
Daimler AG710000
Apple Inc.865985
Amazon906866
Wirecard AG747206
TeslaA1CX3T
NEL ASAA0B733
Beyond MeatA2N7XQ
Allianz840400
BMW AG519000
BASFBASF11
Infineon AG623100
BayerBAY001